(Q54368562)

28 May 2018

title

Augmented induction of antitumor cells in vivo by cyclophosphamide fails to benefit antitumor resistance of the host. (English)

1 reference

28 May 2018

author name string

K Ryoyama

series ordinal

1

1 reference

28 May 2018

C Ryoyama

series ordinal

2

1 reference

28 May 2018

publication date

1 January 1989

1 reference

28 May 2018

Cancer Immunology, Immunotherapy

published in

1 reference

28 May 2018

volume

29

1 reference

28 May 2018

issue

4

1 reference

28 May 2018

page(s)

255-260

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1007/bf00199213

exact match

0 references

cites work

OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.

1 reference

12 December 2020

In vitro reeducated T helper cells from sarcoma-bearing mice inhibit sarcoma growth in vivo.

1 reference

12 December 2020

Potentiation of concanavalin A-bound L1210 vaccine in vivo by chemotherapeutic agents

1 reference

12 December 2020

A 6-thioguanine-resistant variant of the rat mammary adenocarcinoma 13762 that is more immunogenic.

1 reference

12 December 2020

Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice

1 reference

12 December 2020

The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice

1 reference

12 December 2020

Murine sarcoma virus (MSV)-induced tumors in mice. I. Distribution of MSV-immune cytolytic T lymphocytes in vivo

1 reference

12 December 2020

Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice

1 reference

12 December 2020

Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells

1 reference

12 December 2020

Host reactivity to a spontaneous tumor: generation of antitumor activity by lymph node cells following incubation in vitro

1 reference

12 December 2020

Promotion of tumor antigenicity in EL-4 leukemia cells by hydrostatic pressure

1 reference

12 December 2020

Differential cyclophosphamide sensitivity of precursor cells in allogeneic and H-2 restricted cytotoxic responses

1 reference

12 December 2020

Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas

1 reference

12 December 2020

Immunotherapeutic response of concanavalin A-bound L1210 vaccine enhanced by a streptococcal immunopotentiator, OK-432

1 reference

12 December 2020

Effect of OK-432 on immunization with mitomycin-C-treated L1210 cells

1 reference

12 December 2020

Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.

1 reference

12 December 2020

Defective T helper activity in the spleen of BALB/c mice immune to a syngeneic fibrosarcoma

1 reference

12 December 2020

Generation of activated killer cells in tumor-bearing hosts

1 reference

12 December 2020

Studies of the mechanisms for the induction of in vivo tumor immunity. VII. Development of specific antitumor immunity in progressors and regressors

1 reference

12 December 2020

Inhibition of suppressor cell generation by mouse serum in culture.

1 reference

12 December 2020

An extension of the 51Cr-release assay for the estimation of mouse cytotoxins

1 reference

12 December 2020

Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma

1 reference

12 December 2020

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes

1 reference

12 December 2020

Mechanisms of in vivo generation of cytotoxic activity against syngeneic tumours. I. Local differentiation of mature cytotoxic T lymphocytes in the rejection of tumours

1 reference

12 December 2020

Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00199213

1 reference

28 May 2018

1 reference

28 May 2018